10/10/2023 Argaam Exclusive
Shares of Nahdi Medical Co. dropped 2% to close at SAR 137.20, the lowest since debut on the main market (TASI), with nearly 436,000 shares traded.
Highest per Year (Riyal) | Lowest per Year (Riyal) |
209.20 | 137.20 |
Highest since listing (Riyal) | Lowest since listing (Riyal) |
209.40 | 137.20 |
Thus, the stock's year-to-date (YTD) losses reached 16% and 12-month losses hit almost 30%.
Open | 132.80 |
Low | 132.40 |
High | 133.80 |
Previous Close | 132.60 |
Change (3M) | (5.00 %) |
Change (6M) | (5.81 %) |
Market Value | 17,290.00 |
Avg. Volume (3M) | 207,178.27 |
Avg. Turnover (3M) | 27,758,241.80 |
Avg. Transaction (3M) | 2,235.08 |
Change(12M) | (25.45 %) |
YTD | (2.92 %) |
The company did not carry out any changes to its capital since debut in 2022.
Date | Type | Capital (M Riyal) | Change (%) |
2022 | IPO | 1,300.00 | 0.00% |
Financial Ratio | Current |
Market Cap (M Riyal) | 17,290.00 |
Shares Outstanding ((M)) | 130.00 |
EPS ( | ) (TTM)6.78 |
Book Value (BV) ( Riyal) (Latest announcement) | 17.82 |
Adjusted P/E (Last12) | 20.36 |
Price/book | 7.46 |
Dividend Yield (%) (Last Year) | 4.14 |
Return on Average Assets (%) (TTM) | 15.55 |
Return on Average Equity (%) (TTM) | 40.02 |
Par Value ( Riyal) | 10.00 |
Enterprise Value (EV) (M) | 16,520.06 |
Fair Average Price
Number of Recommendations
Rating | Research firm | Current Price | Target Price | Change | |
Neutral | Citi Bank Group | 157.00 | 180.00 | 14.65 % | |
Buy | Riyad Capital | 175.40 | 214.00 | 22.01 % |
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}